51
|
Tian Z, Li J, Zhang S, Xu Z, Yang Y, Kong D, Zhang H, Ge X, Zhang J, Liu Z. Lysosome-Targeted Chemotherapeutics: Half-Sandwich Ruthenium(II) Complexes That Are Selectively Toxic to Cancer Cells. Inorg Chem 2018; 57:10498-10502. [DOI: 10.1021/acs.inorgchem.8b01944] [Citation(s) in RCA: 52] [Impact Index Per Article: 8.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/13/2022]
Affiliation(s)
- Zhenzhen Tian
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Juanjuan Li
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Shumiao Zhang
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Zhishan Xu
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
- Department of Chemistry and Chemical Engineering, Shandong Normal University, Jinan 250014, China
| | - Yuliang Yang
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Deliang Kong
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Hairong Zhang
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Xingxing Ge
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Junming Zhang
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| | - Zhe Liu
- Institute of Anticancer Agents Development and Theranostic Application, The Key Laboratory of Life-Organic Analysis and Key Laboratory of Pharmaceutical Intermediates and Analysis of Natural Medicine, Department of Chemistry and Chemical Engineering, Qufu Normal University, Qufu 273165, China
| |
Collapse
|
52
|
He S, Li C, Zhang Q, Ding J, Liang XJ, Chen X, Xiao H, Chen X, Zhou D, Huang Y. Tailoring Platinum(IV) Amphiphiles for Self-Targeting All-in-One Assemblies as Precise Multimodal Theranostic Nanomedicine. ACS NANO 2018; 12:7272-7281. [PMID: 29906087 DOI: 10.1021/acsnano.8b03476] [Citation(s) in RCA: 89] [Impact Index Per Article: 14.8] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/08/2023]
Abstract
Drug, targeting ligand, and imaging agent are the three essential components in a nanoparticle-based drug delivery system. However, tremendous batch-to-batch variation of composition and drug content typically accompany the current approaches of building these components together. Herein, we report the design of photoactivatable platinum(IV) (Pt(IV)) amphiphiles containing one or two hydrophilic lactose targeting ligands per hydrophobic Pt(IV) prodrug for an all-in-one precise nanomedicine. Self-assembly of these Pt(IV) amphiphiles results in either micelle or vesicle formation with a fixed Pt/targeting moiety ratio and a constantly high content of Pt. The micelles and vesicles are capable of hepatoma cell-targeting, fluorescence/Pt-based CT imaging and have shown effective anticancer efficacy under laser irradiation in vitro and in vivo. This photoactivatable, active self-targeting, and multimodal theranostic amphiphile strategy shows great potential in constructing precise nanomedicine.
Collapse
Affiliation(s)
- Shasha He
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
- University of Chinese Academy of Sciences , Beijing 100049 , P. R. China
| | - Chan Li
- Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and Laboratory of Controllable Nanopharmaceuticals, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , P. R. China
| | - Qingfei Zhang
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
- University of Chinese Academy of Sciences , Beijing 100049 , P. R. China
| | - Jianxun Ding
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
| | - Xing-Jie Liang
- Chinese Academy of Sciences (CAS) Center for Excellence in Nanoscience and Laboratory of Controllable Nanopharmaceuticals, CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety , National Center for Nanoscience and Technology , Beijing 100190 , P. R. China
| | - Xuesi Chen
- Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
| | - Haihua Xiao
- University of Chinese Academy of Sciences , Beijing 100049 , P. R. China
- Beijing National Laboratory for Molecular Sciences, State Key Laboratory of Polymer Physics and Chemistry , Institute of Chemistry, Chinese Academy of Sciences , Beijing 100190 , P. R. China
| | - Xiaoyuan Chen
- Laboratory of Molecular Imaging and Nanomedicine (LOMIN), National Institute of Biomedical Imaging and Bioengineering (NIBIB) , National Institutes of Health (NIH) , Bethesda , Maryland 20892 , United States
| | - Dongfang Zhou
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
| | - Yubin Huang
- State Key Laboratory of Polymer Physics and Chemistry, Changchun Institute of Applied Chemistry , Chinese Academy of Sciences , Changchun 130022 , P. R. China
| |
Collapse
|
53
|
Jain SS, Anderson CM, Sapse IA, Lundgren SH, Freer AK, Hoang H, Jain K, Breshears M. A ruthenium-platinum metal complex that binds to sarcin ricin loop RNA and lowers mRNA expression. Chem Commun (Camb) 2018; 54:8987-8990. [PMID: 29951655 DOI: 10.1039/c8cc02131g] [Citation(s) in RCA: 12] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
Abstract
IT127 is a dinuclear transition metal complex that contains a Pt(ii) and a Ru(iii) metal center. We have shown that IT127 is significantly more effective in binding the 29-base sarcin ricin loop (SRL) RNA in comparison to Cisplatin, a hallmark anticancer agent. Binding site analysis shows that IT127 prefers purine bases and the GAGA tetraloop region of SRL RNA. Our results with a dihydrofolate reductase (DHFR) model system reveal that IT127 binding to mRNA reduces translation of DHFR enzyme and that the Ru(iii) and Pt(ii) centers in IT127 appear to work in a synergistic manner.
Collapse
Affiliation(s)
- Swapan S Jain
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Craig M Anderson
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Iden A Sapse
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Silvie H Lundgren
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Abigail K Freer
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Hang Hoang
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Kyan Jain
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| | - Madeleine Breshears
- Department of Chemistry, Bard College, 30 Campus Road, Annandale-on-Hudson, New York 12504, USA.
| |
Collapse
|
54
|
Zhao J, Li W, Gou S, Li S, Lin S, Wei Q, Xu G. Hypoxia-Targeting Organometallic Ru(II)–Arene Complexes with Enhanced Anticancer Activity in Hypoxic Cancer Cells. Inorg Chem 2018; 57:8396-8403. [DOI: 10.1021/acs.inorgchem.8b01070] [Citation(s) in RCA: 24] [Impact Index Per Article: 4.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Affiliation(s)
- Jian Zhao
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China
| | - Wanchun Li
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Shaohua Gou
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China
| | - Shuang Li
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Shengqiu Lin
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Qianhui Wei
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Gang Xu
- Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China
| |
Collapse
|
55
|
Xu Z, Chan HM, Li C, Wang Z, Tse MK, Tong Z, Zhu G. Synthesis, Structure, and Cytotoxicity of Oxaliplatin-Based Platinum(IV) Anticancer Prodrugs Bearing One Axial Fluoride. Inorg Chem 2018; 57:8227-8235. [PMID: 29943979 DOI: 10.1021/acs.inorgchem.8b00706] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
Fluorine plays more and more important roles in drug design and development. In recent years, fluorine-containing organic drugs have already been applied in a broad range of therapeutic areas. Herein, we report our attempt to introduce an axial fluorine ligand to Pt(IV) complexes by oxidizing oxaliplatin with electrophilic fluorinating reagents in different protic solvents. The crystal structure of one representative complex is presented. The fluorinated Pt(IV) complexes are further expanded by functionalization with different anhydrides, and their analogues bearing one different axial ligand (OAc or OH group) are also synthesized. Further investigations show that the axial fluorine atom has dramatic effects on the chemical properties of these prodrugs. These new fluorinated Pt(IV) complexes are proved to be stable in physiological conditions. For most of the fluorinated Pt(IV) complexes, a higher reduction potential indicates its greater tendency to be reduced by ascorbate. Introducing an axial fluorine ligand in Pt(IV) complexes does not lead to the increase of their lipophilicity. Moreover, these new fluorinated Pt(IV) complexes show better cytotoxicity than nonfluorinated analogues which may derive from their higher cellular accumulation in cancer cells. Therefore, the good stability and high cytotoxicity of these fluorinated Pt(IV) prodrugs indicate their great potential as a building block for further functionalization.
Collapse
Affiliation(s)
- Zoufeng Xu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Ho Ming Chan
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China
| | - Cai Li
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Zhigang Wang
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Man-Kit Tse
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China
| | - Zixuan Tong
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China
| | - Guangyu Zhu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Avenue , Hong Kong SAR 999077 , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| |
Collapse
|
56
|
Elie BT, Pechenyy Y, Uddin F, Contel M. A heterometallic ruthenium-gold complex displays antiproliferative, antimigratory, and antiangiogenic properties and inhibits metastasis and angiogenesis-associated proteases in renal cancer. J Biol Inorg Chem 2018; 23:399-411. [PMID: 29508136 PMCID: PMC6173830 DOI: 10.1007/s00775-018-1546-8] [Citation(s) in RCA: 42] [Impact Index Per Article: 7.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/12/2018] [Accepted: 02/16/2018] [Indexed: 12/13/2022]
Abstract
Heterobimetallic compounds are designed to harness chemotherapeutic traits of distinct metal species into a single molecule. The ruthenium-gold (Ru-Au) family of compounds based on Au-N-heterocyclic carbene (NHC) fragments [Cl2(p-cymene)Ru(μ-dppm)Au(NHC)]ClO4 was conceived to combine the known antiproliferative and cytotoxic properties of Au-NHC-based compounds and the antimigratory, antimetastatic, and antiangiogenic characteristic of specific Ru-based compounds. Following recent studies of the anticancer efficacies of these Ru-Au-NHC complexes with promising potential as chemotherapeutics against colorectal, and renal cancers in vitro, we report here on the mechanism of a selected compound, [Cl2(p-cymene)Ru(μ-dppm)Au(IMes)]ClO4 (RANCE-1, 1). The studies were carried out in vitro using a human clear cell renal carcinoma cell line (Caki-1). These studies indicate that bimetallic compound RANCE-1 (1) is significantly more cytotoxic than the Ru (2) or Au (3) monometallic derivatives. RANCE-1 significantly inhibits migration, invasion, and angiogenesis, which are essential for metastasis. RANCE-1 was found to disturb pericellular proteolysis by inhibiting cathepsins, and the metalloproteases MMP and ADAM which play key roles in the etiopathogenesis of cancer. RANCE-1 also inhibits the mitochondrial protein TrxR that is often overexpressed in cancer cells and facilitates apoptosis evasion. We found that while auranofin perturbed migration and invasion to similar degrees as RANCE-1 (1) in Caki-1 renal cancer cells, RANCE-1 (1) inhibited antiangiogenic formation and VEGF expression. We found that auranofin and RANCE-1 (1) have distinct proteolytic profiles. In summary, RANCE-1 constitutes a very promising candidate for further preclinical evaluations in renal cancer.
Collapse
Affiliation(s)
- Benelita T Elie
- Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, NY, 11210, USA
- Biology PhD Program, The Graduate Center, The City University of New York, 365 Fifth Avenue, New York, NY, 10016, USA
- Biology Department, The City College of New York, City University of New York, New York, NY, 10031, USA
| | - Yuriy Pechenyy
- Biology Department, The City College of New York, City University of New York, New York, NY, 10031, USA
| | - Fathema Uddin
- Biology Department, The City College of New York, City University of New York, New York, NY, 10031, USA
| | - María Contel
- Department of Chemistry, Brooklyn College, The City University of New York, Brooklyn, NY, 11210, USA.
- Biology PhD Program, The Graduate Center, The City University of New York, 365 Fifth Avenue, New York, NY, 10016, USA.
- Chemistry PhD Program, The Graduate Center, The City University of New York, 365 Fifth Avenue, New York, NY, 10016, USA.
| |
Collapse
|
57
|
Ma L, Lin X, Li C, Xu Z, Chan CY, Tse MK, Shi P, Zhu G. A Cancer Cell-Selective and Low-Toxic Bifunctional Heterodinuclear Pt(IV)-Ru(II) Anticancer Prodrug. Inorg Chem 2018; 57:2917-2924. [PMID: 29436828 DOI: 10.1021/acs.inorgchem.8b00053] [Citation(s) in RCA: 48] [Impact Index Per Article: 8.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/06/2023]
Abstract
Although different types of metal-based anticancer complexes have been synthesized, novel complexes to reduce the serious side effect of cisplatin and conquer cancer metastasis are still highly desired. Here, we report the synthesis, characterization, and biological activity of a novel heterodinuclear Pt(IV)-Ru(II) anticancer prodrug. The Pt(IV)-Ru(II) complex exhibits good stability in both water and PBS solution. Biological evaluation revealed that this bifunctional Pt(IV)-Ru(II) complex utilizes the advantages of two metal centers to have both cytotoxicity and antimetastatic property as designed. Although the complex has comparable cytotoxicities to cisplatin in tested cancer cell lines, this prodrug selectively kills cancer but not normal cells, and the IC50 values of the Pt(IV)-Ru(II) complex are 7-10 times higher than those of cisplatin toward normal cells. The cancer cell selectivity is further demonstrated by a cancer-normal cell coculture system. In addition, the antimetastatic properties of the heterodinuclear complex are assessed by using highly metastatic human breast cancer cells, and the results show that the migration and invasion of cancer cells are effectively restrained after the treatment. Moreover, the Pt(IV)-Ru(II) complex displays lower toxicity than cisplatin in developing zebrafish embryos. We, therefore, report an example of heterodinuclear Pt(IV)-Ru(II) complex not only to defeat both drug resistance and cancer metastasis but also having significantly improved cancer cell selectivity and reduced in vivo toxicity than cisplatin.
Collapse
Affiliation(s)
- Lili Ma
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Xudong Lin
- Department of Biomedical Engineering , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China
| | - Cai Li
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Zoufeng Xu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| | - Chun-Yin Chan
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China
| | - Man-Kit Tse
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China
| | - Peng Shi
- Department of Biomedical Engineering , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China
| | - Guangyu Zhu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Hong Kong SAR , People's Republic of China.,City University of Hong Kong Shenzhen Research Institute , Shenzhen 518057 , People's Republic of China
| |
Collapse
|
58
|
Huang X, Hua S, Huang R, Liu Z, Gou S, Wang Z, Liao Z, Wang H. Dual-targeting antitumor hybrids derived from Pt(IV) species and millepachine analogues. Eur J Med Chem 2018; 148:1-25. [PMID: 29448138 DOI: 10.1016/j.ejmech.2018.02.012] [Citation(s) in RCA: 25] [Impact Index Per Article: 4.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/28/2017] [Revised: 02/04/2018] [Accepted: 02/05/2018] [Indexed: 12/21/2022]
Abstract
Many strategies have been developed to circumvent the shortcomings of Pt(II)-based chemotherapy, but the inherent problems still have not been effectively resolved. Here we report a new series of dual-targeting Pt(IV) prodrugs, conjugates of millepachine analogues with the related Pt(IV) complexes derived from cisplatin or oxaliplatin, respectively, which can inhibit tubulin polymerization and induce DNA damage. Among them, compound 19 possessed excellent antitumor activities against the tested human cancer cell lines, and arrested the cell cycle at the G2/M phases and ultimately induced cell apoptosis. Interestingly, its low cytotoxicity toward two human normal cells and sensitivity toward two cisplatin-resistant cells revealed the possibility for cancer therapy. More importantly, 19 displayed excellent antitumor efficacy in the SK-OV-3 xenograft model better than cisplatin and the corresponding millepachine analogue. Our research provided an efficient strategy for multi-targeting antitumor drug development.
Collapse
Affiliation(s)
- Xiaochao Huang
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Shixian Hua
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Rizhen Huang
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Zhikun Liu
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Shaohua Gou
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China.
| | - Zhimei Wang
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Zhixin Liao
- Jiangsu Province Hi-Tech Key Laboratory for Biomedical Research, Southeast University, Nanjing 211189, China; Pharmaceutical Research Center and School of Chemistry and Chemical Engineering, Southeast University, Nanjing 211189, China
| | - Hengshan Wang
- State Key Laboratory for the Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry and Pharmaceutical Sciences of Guangxi Normal University, Guilin 541004, China.
| |
Collapse
|
59
|
Fang T, Ye Z, Wu J, Wang H. Reprogramming axial ligands facilitates the self-assembly of a platinum(iv) prodrug: overcoming drug resistance and safer in vivo delivery of cisplatin. Chem Commun (Camb) 2018; 54:9167-9170. [PMID: 30062328 DOI: 10.1039/c8cc03763a] [Citation(s) in RCA: 26] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
We herein reprogrammed axial ligands of platinum(iv) prodrugs, conferring the constructed prodrug entities with the ability to self-assemble in aqueous solution.
Collapse
Affiliation(s)
- Tao Fang
- Jinhua People's Hospital
- Jinhua
- P. R. China
| | - Zhijian Ye
- Jinhua People's Hospital
- Jinhua
- P. R. China
| | - Jiaping Wu
- The First Affiliated Hospital
- Key Laboratory of Combined Multi-Organ Transplantation
- Ministry of Public Health
- School of Medicine
- Zhejiang University
| | - Hangxiang Wang
- The First Affiliated Hospital
- Key Laboratory of Combined Multi-Organ Transplantation
- Ministry of Public Health
- School of Medicine
- Zhejiang University
| |
Collapse
|
60
|
Rahman FU, Bhatti MZ, Ali A, Duong HQ, Zhang Y, Yang B, Koppireddi S, Lin Y, Wang H, Li ZT, Zhang DW. Homo- and heteroleptic Pt(II) complexes of ONN donor hydrazone and 4-picoline: A synthetic, structural and detailed mechanistic anticancer investigation. Eur J Med Chem 2018; 143:1039-1052. [DOI: 10.1016/j.ejmech.2017.11.044] [Citation(s) in RCA: 20] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/09/2017] [Revised: 11/15/2017] [Accepted: 11/17/2017] [Indexed: 11/17/2022]
|
61
|
Li C, Ip KW, Man WL, Song D, He ML, Yiu SM, Lau TC, Zhu G. Cytotoxic (salen)ruthenium(iii) anticancer complexes exhibit different modes of cell death directed by axial ligands. Chem Sci 2017; 8:6865-6870. [PMID: 29147511 PMCID: PMC5632802 DOI: 10.1039/c7sc02205k] [Citation(s) in RCA: 37] [Impact Index Per Article: 5.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/16/2017] [Accepted: 07/27/2017] [Indexed: 12/12/2022] Open
Abstract
A cancer-cell selective bis(guanidine)-ruthenium(iii) complex induces apoptosis, whereas its amidine analogue effectively kills cancer cells through paraptosis pathways.
Two novel series of (salen)ruthenium(iii) complexes bearing guanidine and amidine axial ligands were synthesized, characterized, and evaluated for anticancer activity. In vitro cytotoxicity tests demonstrate that these complexes are cytotoxic against various cancer cell lines and the leading complexes have remarkable cancer-cell selectivity. A detailed study of the guanidine complex 7 and the amidine complex 13 reveals two distinguished modes of action. Complex 7 weakly binds to DNA and induces DNA damage, cell cycle arrest, and typical apoptosis pathways in MCF-7 cells. In contrast, complex 13 induces paraptosis-like cell death hallmarked by massive vacuole formation, mitochondrial swelling, and ER stress, resulting in significant cytotoxicity against human breast cancer cells. Our results provide an extraordinary example of tuning the mechanism of action of (salen)ruthenium(iii) anticancer complexes by modifying the structure of the axial ligands.
Collapse
Affiliation(s)
- Cai Li
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ; .,City University of Hong Kong Shenzhen Research Institute , Shenzhen , P. R. China
| | - Kwok-Wa Ip
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ;
| | - Wai-Lun Man
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ;
| | - Dan Song
- Department of Biomedical Sciences , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR
| | - Ming-Liang He
- Department of Biomedical Sciences , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR
| | - Shek-Man Yiu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ;
| | - Tai-Chu Lau
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ; .,Institute of Molecular Functional Materials , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR
| | - Guangyu Zhu
- Department of Chemistry , City University of Hong Kong , 83 Tat Chee Ave , Kowloon Tong , Hong Kong SAR . ; .,City University of Hong Kong Shenzhen Research Institute , Shenzhen , P. R. China
| |
Collapse
|
62
|
Xu Z, Li C, Tong Z, Ma L, Tse MK, Zhu G. Halogenated PtIVComplexes fromN-Halosuccinimide Oxidation of PtIIAntitumor Drugs: Synthesis, Mechanistic Investigation, and Cytotoxicity. Eur J Inorg Chem 2016. [DOI: 10.1002/ejic.201601130] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- Zoufeng Xu
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
- City University of Hong Kong Shenzhen Research Institute; Shenzhen P. R. China
| | - Cai Li
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
- City University of Hong Kong Shenzhen Research Institute; Shenzhen P. R. China
| | - Zixuan Tong
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
| | - Lili Ma
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
- City University of Hong Kong Shenzhen Research Institute; Shenzhen P. R. China
| | - Man-Kit Tse
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
| | - Guangyu Zhu
- Department of Biology and Chemistry; City University of Hong Kong; 83 Tat Chee Ave Kowloon, Hong Kong SAR P. R. China
- City University of Hong Kong Shenzhen Research Institute; Shenzhen P. R. China
| |
Collapse
|